Transition Therapeutics Inc (NASDAQ:TTHI)

Delayed Data
As of 9:54am ET
 -0.07 / -1.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Transition Therapeutics Inc have a median target of 9.38, with a high estimate of 10.00 and a low estimate of 8.77. The median estimate represents a +37.19% increase from the last price of 6.84.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Transition Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 59.17%
Growthannually -60.76%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account